Solving the Puzzle
of Lung Cancer Complexity
with Artificial Intelligence

What is I3LUNG

I3LUNG is a European project funded under the framework of the Horizon Europe (HEurope) call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.

For Patients

In the video below the project explained by Anne-Marie Baird, President of Lung Cancer Europe (LuCE) (one of the partners of the I3LUNG).

We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry. (I3LUNG Partners)

Find out the most relevant news on the latest advancements in lung cancer!

I3LUNG Partners Meet at MEDSIR’s Office

Last Friday, MEDSIR’s office hosted a meeting for the I3LUNG partners: Vall d’Hebron Institute of Oncology (VHIO), Universitätsklinikum Hamburg Eppendorf, […]

Great insights at the ” ESMO Molecular Analysis for Precision Oncology Congress 2024 ” in London!

During the session on “Ethical and Regulatory Aspects for Implementing AI in Clinical Trials,” Arsela Prelaj, our I3LUNG partner from Fondazione IRCCS Istituto […]

I3LUNG participates in Cancer Core Europe’s summer with AI-Powered Oncology solutions

I3LUNG made an appearance at “Cancer Core Europe’s Summer School in Translational Cancer Research 2024”, in Albufeira (Portugal). On October 9, […]